Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert J Michel is Chief Financial Officer at Daxor. OQRO lists 3 transactions filed with the SEC under this name, the latest on Jun 25, 2026, each linked to the official Form 4.
Chief Financial Officer
Disclosures on record
3
Companies involved
1
2 buys, median −0.6 pts vs S&P 500, beat it 1 of 2 times.
Average −0.6 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Mar 11, 2025 to Mar 31, 2026, measured from the first close after the filing. Past results, not a forecast.
2 purchases disclosed; 50% of the 2 measured at 90 days finished ahead of the index. $1,000 placed after each of the 1 purchases disclosed since 2025-11-16 would be worth $881 today ($1K put in); the same in the S&P 500 (SPY): $1.2K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
DaxorDXR
3 disclosures · Mar 2025 – Jun 2026 · 2 bought
Jun 23, 202612Kdisclosed Jun 25
DetailsOfficial recordMar 31, 2026Bought~$9.9K
DetailsOfficial recordEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Mar 10, 2025Bought~$8Kdisclosed Mar 11
DetailsOfficial recordAs of the latest filing on , Robert J Michel reported holding 33,050 shares of Daxor (DXR), worth about $276K at the last close of $8 (Nov 16, 2026). In the last 12 months, Robert J Michel bought $9.9K in 1 open-market purchase.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Daxor DXR | 33,050 | 33K direct | $8 | $276K | Jun 23, 2026 |
Is this Robert J Michel’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Robert J Michel bought shares on the open market in 8 different years since 2018 across 2 companies.
Robert J Michel reported 12 open-market purchases and 0 sales since 2018; purchases in 8 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $9.9K1×1 trade | — |
| 2025 | $8K1×1 trade | — |
| 2024 | $6.5K1×1 trade | — |
| 2023 | $11K4×4 trades | — |
| 2022 | $10K1×1 trade | — |
| 2021 | $10K1×1 trade | — |
| 2019 | $9.8K1×1 trade | — |
| 2018 | $25K2×2 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jun 23, 2026, Robert J Michel reported holding 33,050 shares of Daxor (DXR). At the last close of $8 on Nov 16, 2026, that is about $276K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Robert J Michel reported 1 open-market purchase worth $9.9K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Robert J Michel bought shares on the open market in 8 different years since 2018 across 2 companies.
In SEC filings since 2018: the latest open-market purchase is from 2026; no open-market sale is on record.
2 companies: Daxor (DXR, 2018–2026), Bio Key International (BKYI, 2018).
Robert J Michel reported 11 open-market purchases and 0 sales here, 2018 to 2026.
Robert J Michel reported 1 open-market purchase and 0 sales here, 2018.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.